Toll Free: 1800 103 1369 Email Us:customercare@canmoney.in

Markets

Market

AAREY DRUGS & PHARMACEUTICALS LTD.

  • NSE CodeAAREYDRUGSBE
  • BSE Code524412
  • ISININE198H01019
  • IndustryPharmaceuticals


Company Information

Management

Mr. Mira M Ghatalia

Chief Financial Officer

Mr. Kailash Chand Jethlia

Co. Secretary & Compl. Officer

Incorporation Year

15/05/1990

Registered Address

Registered Office & Factory : E-34, M.I.D.C., , Tarapur, Boisar,
Thane, Maharashtra - 401506
Tel: 022-2271049, 2272313, 23455543
Fax: 022-66154219

Registrar Office

MUFG Intime India Pvt. Ltd.
C 101, 247 Park, L.B.S. Marg, Vikhroli (West)
Mumbai,400083,Maharashtra
Tel: 022-49186270
Fax: 49186060

Email

investorgrievance@aareydrugs.com

Website

http://www.aareydrugs.com

Listing

BSE, NSE

Corporate News

Aarey Drugs&Pharma. has submitted to BSE the Sharehol...

21-Jul-2026|8:20PM

As of June 2026, 37.71% is owned by Indian Promoters and 62.29% by Public.

Aarey Drugs&Pharma. - Certificate under SEBI (Deposit...

08-Jul-2026|3:02PM

Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about Certi

Aarey Drugs&Pharma. - Compliances-Certificate under R...

08-Jul-2026|2:51PM

Compliance Certificate under Reg 74(5) of Sebi(DP) Regulation 2018

Aarey Drugs&Pharma. - Disclosure under SEBI Takeover ...

06-Jul-2026|11:58AM

Nimit Rajesh Ghatalia has Submitted to the Exchange a copy of Disclosure un

More

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug77.86220.77
Aarti Drug422.753,858.44
Aarti Pharma667.156,049.70
Abbott India27,800.0059,073.06
Accent Micro508.101,218.88
More

MF Holding

No Data Available

Board Meetings

DatePurpose
30/05/2026Audited Results
11/02/2026Quarterly Results
13/11/2025Quarterly Results
13/08/2025Quarterly Results
30/05/2025Audited Results
More
Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....................issued in the interest of investors.
KYC is one-time exercise while dealing in securities markets -> Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
CDSL – MyEasi App App Store: https://apps.apple.com/in/app/cdsl-myeasi-app/id6737304195      Google Play Store: https://play.google.com/store/apps/details?id=com.cdsl.myeasi   |   NSDL – Speede App : App Store: https://apps.apple.com/in/app/nsdl-speede-app/id922834763      Google Play Store: https://play.google.com/store/apps/details?id=com.msf.NSDL.Android